Theories which are mainly based on cell have great prospective in repairing, replacing, restoring and in regenerating damaged cells, tissues and organs. The application of cell therapy is applied potentially in treatment of cancer, infectious and autoimmune disease, improving a weakened immune system, urinary problems, repairmen of the spinal cord injuries, rebuilding damaged cartilage in the joints, and assisting individuals with neurological disorders. The theory helps in exploring and developing custom-made medicine for treating a number of medical disorders.
Market Statistics
Globally, the market of cell therapy is forecasted to report for US$ 7,321.7 million as per value by 2022.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5413
Drivers
Rise in the applications of therapeutics of the cell-based therapies is anticipated to increase the market growth of the market of cell therapy worldwide in the predicted period. For example, cell-based treatments are needed in improving the immune system of the body to fight against cancer. Therefore, with the rise in cancer problems, the application of the cell-based treatments is also rising at an increased pace. The U.S. Food and Drug Administration (FDA) in March 2022, permitted Carvykti (ciltacabtagene autoleucel; cilta-cel) for treating adults having relapsed or refractory multiple myeloma after four or more prior lines of therapy, with a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody.
Opportunities
Increasing incidence of prolonged conditions worldwide is anticipated to offer substantial opportunities of growth for the companies in the market of cell therapy worldwide. For example, cell therapies give an encouraging approach in treating chronic, and therefore, the applications of cell therapies has raised across the world. As per WHO, chronic diseases like cancer are the main reason of death and disability across the world. FDA in March 2021, permitted Abecma (idacabtagene vicleucel) which is a cell based therapy for treating adult patients suffering from multiple myeloma. Abecma is a maiden cell-based gene therapy consented by FDA.
Restraints
The cell therapy/treatment involves high cost and the reimbursement policy is also poor which is the main cause of hampering the market for cell therapy worldwide. For example, the normal treatment cost with Novartis’ Kymriah is approximately US$ 475,000 that of Kite Pharma/Gilead’s Yescarta is US$ 373,000. The only FDA approved chimeric receptor (CAR) T-cell therapy is Kymriah whereas Yescarta is the EC(European Commission) approved chimeric antigen receptor (CAR) T-cell therapy.
Global Cell Therapy Market- Impact of Coronavirus (Covid-19) Pandemic
The COVID-19 pandemic had a positive effect on the market of cell therapy since most companies across the world have emphasized on the growth of the cell therapies for treating COVID-19. For example, the U.S. Food and Drug Administration (FDA) in April 2022 permitted BioCardia’s COVID-19 stem cell therapy trial. The primary part of the trial will evaluate the rising doses of NK1R+ MSCs and the optimum dose will be chosen for the randomized Phase II trials in adult subjects to recover from COVID-19 associated acute respiratory distress syndrome or ARDS, since the stem cell plays an important psrt in battling against COVID-19.
Key Takeaways
Globally, the market for cell therapy was priced at US$ 6,876.8 million in the year 2021 and is estimated to the extent of US$ 10,944.3 million by the end of the year 2028 at a CAGR of 6.9% from 2022 to 2028.
Considering therapy, the segment of mesenchymal stem cell therapy holds a dominating position in the market of stem cell therapy worldwide in the year 2021, reporting for 39.1% share value, raising the consent and introduction of novel products is anticipated to fuel the segment’s growth in the predicted period.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5413
Market Trends
Cell therapy has evolved as a cutting age treatment for the pharmaceutical companies worldwide in the R&D (research and development) of innovative treatment in treating a large array of medical disorders. Furthermore, cell therapies have the prospective in exploring and developing custom-made medicine for carrying out therapies for a number of medical disorders. This tendency is anticipated too, to last in the predicted period, pushing the market growth for cell therapy worldwide.
Competitive Landscape
The main companies functioning in the market of cell therapy worldwide are Stempeutics Research Pvt. Ltd., Medipost Co. Ltd., Nipro Corporation, Dendreon Pharmaceuticals LLC, Organogenesis Inc., Novartis AG, Vericel Corporation, Allogene Therapeutics Inc., Gilead Sciences Inc. (Kite Pharma Inc.), and Takeda Pharmaceutical Company Limited (TiGenix), among others.
Recent Developments
Novartis AG in July 2020 received the approval from the European Medicines Agency’s (EMA) for two of its sites for commercial manufacturing of CAR-T cell therapy.
Gilead Sciences Inc. and oNKO –Innate in April 2020, announced a partnership in supporting the research, discovery and development of the future cell therapies based on NK cells.
Allogene Therapeutics Inc. in June 2019 got the approval of the U.S Food and Drug Administration (FDA) for its usage of Allogene’s Investigational New Drug for Allo-715 (BCMA AlloCar T Therapy)
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5413
Table of Contents:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Therapy
- Market Snapshot, By Application
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in incidence/prevalence of chronic diseases
- High cost of cell-based therapies
- Increase focus on the development of novel therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Market Dynamics
- Global Cell Therapy Market– Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- Global Cell Therapy Market, By Type, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
- Global Cell Therapy Market, By Therapy, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Mesenchymal Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Fibroblast Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Hematopoietic Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Other Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
- Global Cell Therapy Market, By Application, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Malignancies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Cardiovascular, Dermatology and Wounds, and Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Dermatology and Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Introduction
Explore More Insights:
Plasmid dna manufacturing market
Gmp protein e coli contract manufacturing market
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com